M
Maccura Biotechnology Co Ltd
SZSE:300463
Maccura Biotechnology Co Ltd
SZSE:300463
Price:
12.82 CNY
-1%
Market Closed
Updated:
May 29, 2024
Maccura Biotechnology Co Ltd
Additional Paid In Capital
|
Maccura Biotechnology Co Ltd
Additional Paid In Capital Peer Comparison
Comparables:
603259
300759
2269
300347
M
688114
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
M
|
Maccura Biotechnology Co Ltd
SZSE:300463
|
Additional Paid In Capital
¥1.8B
|
CAGR 3-Years
76%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Additional Paid In Capital
¥28.4B
|
CAGR 3-Years
6%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Additional Paid In Capital
¥5.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Additional Paid In Capital
¥24.5B
|
CAGR 3-Years
15%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Additional Paid In Capital
¥11.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
55%
|
CAGR 10-Years
39%
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Additional Paid In Capital
¥8.7B
|
CAGR 3-Years
109%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Maccura Biotechnology Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
1.8B
CNY
1.8B
CNY
Based on the financial report for Mar 31, 2024, Maccura Biotechnology Co Ltd's Additional Paid In Capital amounts to 1.8B CNY.
What is Maccura Biotechnology Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
29%
29%
Over the last year, the Additional Paid In Capital growth was 0%. The average annual Additional Paid In Capital growth rates for Maccura Biotechnology Co Ltd have been 76% over the past three years , 29% over the past five years .
You don't have any saved screeners yet
